Ignite Creation Date:
2025-12-24 @ 10:30 PM
Ignite Modification Date:
2026-02-01 @ 7:31 PM
Study NCT ID:
NCT04991935
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-18
First Post:
2021-07-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
Sponsor:
Celgene
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Eosinophilic Esophagitis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Eosinophilic Esophagitis | View |
| None | CC-93538 | View |
| None | RPC4046 | View |
| None | Adult | View |
| None | Adolescent | View |
| None | Gastrointestinal Diseases | View |
| None | Esophagitis | View |
| None | Gastroenteritis | View |
| None | Eosinophils | View |
| None | Eosinophilia | View |
| None | Esophageal Diseases | View |
| None | Allergic Diseases | View |
| None | Antibody, Monoclonal | View |
| None | Hypersensitivity | View |
| None | Immunologic factors | View |
| None | Physiological Effects of Drugs | View |
| None | Cendakimab | View |